Form 8-K SCICLONE PHARMACEUTICALS For: Aug 09
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- L3Harris CEO steps down amid conduct review, shares drop
- Oil settles up over $2 as Iran war stalemate stokes supply concerns
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
Sciclone Pharma (SCLN) Reports Q2 EPS of $0.20
August 9, 2016 4:59 PM EDTSciclone Pharma (NASDAQ: SCLN) reported Q2 EPS of $0.20, versus $0.26 reported last year. Revenue for the quarter came in at $39 million, versus $37.9 million reported last year.
Outlook for 2016
SciClone projects its 2016 revenue to be in the range of $158 million... More
